Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-03

Clinical Trial Update: A Fatty Acids Study in Preventing Retinopathy of Prematurity [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a fatty acids intervention for preventing retinopathy of prematurity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fatty acids supplement (fatty acids)

Snippet

Sponsor: Carola Pfeiffer-Mosesson | Conditions: Retinopathy of Prematurity | Phase 3 | Status: COMPLETED